Save Product
Product Details
Source
Monoclonal Anti-Biotin Antibody, Rabbit IgG (M1A01) is a rabbit monoclonal antibody recombinantly expressed in HEK293 cells.
Antibody Type
Recombinant Monoclonal
Clone
M1A01
Isotype
Rabbit IgG, Kappa
Host Species
Rabbit
Immunogen
Biotin-BSA
Specificity
Specifically binds to biotinylated proteins without recognizing non‑biotinylated proteins.
Purification
Protein A purified / Protein G purified.
Aggregation
Less than 10%, as determined by SEC-MALS.
Concentration
Please refer to the Certificate of Analysis (CoA).
Form
Lyophilized
Formulation
Lyophilized from a 0.22 μm-filtered solution in PBS (pH 7.4), with trehalose as protectant.
Please contact us for customized product forms or formulations.
Reconstitution
Please refer to the Certificate of Analysis (CoA) for specific instructions.
Shipping
Lyophilized product is shipped at ambient temperature.
Storage
For long term storage, the product should be stored in a lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- -20°C to -70°C for 12 months in lyophilized state;
- -70°C for 3 months under sterile conditions after reconstitution.
Notices
Product Specific Notices: For research use only.
ACRO Quality Management System
Customers Also Viewed
Performance Data
Bioactivity-ELISA
Immobilized Biotinylated Human LILRB4, His,Avitag (Cat. No. LI4-H82E4) at 1 μg/mL (100 μL/well) can bind Monoclonal Anti-Biotin Antibody, Rabbit IgG (M1A01) (Cat. No. BIN-MY2297) with a linear range of 0.06-1 ng/mL (QC tested).
Protocol
Immobilized Biotinylated Human LILRB4, His,Avitag (Cat. No. LI4-H82E4) at 1 μg/mL (100 μL/well) can bind Monoclonal Anti-Biotin Antibody, Rabbit IgG (M1A01) (Cat. No. BIN-MY2297) with a linear range of 0.1-1 ng/mL. Human LTBR Protein, His,Avitag (Cat. No. LTR-H52E3) is verified not recoginized by Monoclonal Anti-Biotin Antibody, Rabbit IgG (M1A01) (Cat. No. BIN-MY2297) in low concentration (Routinely tested).
Protocol
Customer Reviews Writing Reviews
Background
Recent Advances
Contact Us
[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521
Drug Candidate Licensing
